Last Updated on Nov 13, 2026

Anti-Cancer Drugs- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Lippincott Williams and Wilkins

Abbreviation: Anti-Cancer Drugs




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.96

SJR

 0.506

h-Index

 106

Rank

 11762

Important Details

Title Anti-Cancer Drugs
Standard Abbreviation Anti-Cancer Drugs
Type of Publication Journal
Discipline Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Cancer Research (Q4)
Impact Score 1.96
SCImago Journal Rank (SJR) 0.506
h-index 106
Overall Rank 11762
Publisher Name Lippincott Williams and Wilkins
Publication Country United States
International Standard Serial Number (ISSN) 09594973, 14735741
Coverage and History 1990-2026
Best Quartile Q3
Total Citations Received
(Last 3 Year)
1033

About Anti-Cancer Drugs


Anti-Cancer Drugs is a journal published by Lippincott Williams and Wilkins. This journal covers the area[s] related to Oncology, Pharmacology, Pharmacology (medical), Cancer Research, etc. The coverage history of this journal is as follows: 1990-2026. The rank of this journal is 11762. This journal's impact score, h-index, and SJR are 1.96, 106, and 0.506, respectively. The ISSN of this journal is/are as follows: 09594973, 14735741.

The best quartile of Anti-Cancer Drugs is Q3. This journal has received a total of 1033 citations during the last three years (Preceding 2025).


Anti-Cancer Drugs Impact Score 2025-2026


The latest impact score (IS) of the Anti-Cancer Drugs is 1.96. It is computed in the year 2026 as per its definition and based on Scopus data. 1.96

It is decreased by a factor of around 0.17, and the percentage change is -7.98% compared to the preceding year 2024, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Anti-Cancer Drugs Impact Score 2026


Impact Score 2025 of Anti-Cancer Drugs is 1.96. If a similar downward trend continues, IS may decrease in 2026 as well.


Impact Score Graph


Check below the Impact Score trends of Anti-Cancer Drugs. This is based on Scopus data.


Year Impact Score (IS)
2026/2027 Coming Soon
2025 1.96
2024 2.13
2023 1.89
2022 2.23
2021 2.26
2020 2.11
2019 2.38
2018 1.88
2017 1.77
2016 2.52
2015 2.41
2014 2.07

Anti-Cancer Drugs h-index


  Table Setting

The h-index of Anti-Cancer Drugs is 106. By definition of the h-index, this journal has at least 106 published articles with more than 106 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Anti-Cancer Drugs ISSN


The International Standard Serial Number (ISSN) of Anti-Cancer Drugs is/are as follows: 09594973, 14735741.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Anti-Cancer Drugs Ranking and SCImago Journal Rank (SJR)


The Anti-Cancer Drugs is ranked 11762 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.506.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Anti-Cancer Drugs Publisher


Table Setting

The publisher of Anti-Cancer Drugs is Lippincott Williams and Wilkins. The publishing house of this journal is located in the United States. Its coverage history is as follows: 1990-2026.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Anti-Cancer Drugs is Anti-Cancer Drugs. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Anti-Cancer Drugs') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Anti-Cancer Drugs


If your area of research or discipline is related to Oncology, Pharmacology, Pharmacology (medical), Cancer Research, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Anti-Cancer Drugs?

The latest impact score of Anti-Cancer Drugs is 1.96. It is computed in the year 2026.


What is the h-index of Anti-Cancer Drugs?

The latest h-index of Anti-Cancer Drugs is 106. It is evaluated in the year 2026.


What is the SCImago Journal Rank (SJR) of Anti-Cancer Drugs?

The latest SCImago Journal Rank (SJR) of Anti-Cancer Drugs is 0.506. It is calculated in the year 2026.


What is the ranking of Anti-Cancer Drugs?

The latest ranking of Anti-Cancer Drugs is 11762. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2026.


Who is the publisher of Anti-Cancer Drugs?

Anti-Cancer Drugs is published by Lippincott Williams and Wilkins. The publication country of this journal is United States.


What is the abbreviation of Anti-Cancer Drugs?

This standard abbreviation of Anti-Cancer Drugs is Anti-Cancer Drugs.


Is "Anti-Cancer Drugs" a Journal, Conference or Book Series?

Anti-Cancer Drugs is a journal published by Lippincott Williams and Wilkins.


What is the scope of Anti-Cancer Drugs?

The scope of Anti-Cancer Drugs is as follows:

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Cancer Research

For detailed scope of Anti-Cancer Drugs, check the official website of this journal.


What is the ISSN of Anti-Cancer Drugs?

The International Standard Serial Number (ISSN) of Anti-Cancer Drugs is/are as follows: 09594973, 14735741.


What is the best quartile for Anti-Cancer Drugs?

The best quartile for Anti-Cancer Drugs is Q3.


What is the coverage history of Anti-Cancer Drugs?

The coverage history of Anti-Cancer Drugs is as follows 1990-2026.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Current Sociology Journal SAGE Publications Ltd 4830 90 3.53
IEEE/OSA Journal of Display Technology Journal IEEE Computer Society 12809 68 0.00
Entrepreneurship Theory and Practice Journal SAGE Publications Ltd 232 224 12.12
Journal of Classical Sociology Journal SAGE Publications Ltd 15585 34 0.84
Marine Biology Research Journal Taylor and Francis Ltd. 15718 66 1.24
Syntax Journal Wiley-Blackwell Publishing Ltd 8098 37 0.80
Libyan Studies Journal Cambridge University Press 17889 11 0.64
Sapporo Medical Journal Journal Sapporo Medical University 30716 3 0.00
Indian Phytopathology Journal Springer 17628 24 1.16
Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria Journal National Association of Resident Doctors of Nigeria 25905 25 0.00

Check complete list




Anti-Cancer Drugs Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2026/2027 Updated Soon
2025 1.96
2024 2.13
2023 1.89
2022 2.23
2021 2.26
2020 2.11
2019 2.38
2018 1.88
2017 1.77
2016 2.52
2015 2.41
2014 2.07



Top Journals/Conferences in Oncology

Cancer Microenvironment
Springer Netherlands | Netherlands

Current Colorectal Cancer Reports
Springer Science + Business Media | United States

Australian Journal of Cancer Nursing
Cambridge Media | Australia

Clinical Sarcoma Research
BioMed Central Ltd. | United Kingdom

Onkologe
Springer Verlag | Germany

Onkopediatria
Paediatrician Publishers, LLC | Russian Federation

See All

Top Journals/Conferences in Pharmacology

Human gene therapy methods
Mary Ann Liebert Inc. | United States

Frontiers in Clinical Drug Research - Alzheimer Disorders
Bentham Science Publishers B.V. | Netherlands

P and T
MediMedia USA Inc. | United States

Journal of Population Therapeutics and Clinical Pharmacology
Dougmar Publishing Group Inc. | Canada

Clinical Medicine Insights: Therapeutics
Libertas Academica Ltd. | New Zealand

Pharmacien Hospitalier et Clinicien
Elsevier Masson s.r.l. | France

PharmacoVigilance Review
Euromed Communications | United Kingdom

Clinical Pharmacist
Pharmaceutical Press | United Kingdom

Australian Journal of Pharmacy
Australian Pharmaceutical Publishing Company Ltd | Australia

Archivos Venezolanos de Farmacologia y Terapeutica
Sociedad Latinoamericana de Hipertension | Venezuela

Journal of Pharmaceutical Negative Results
Wolters Kluwer Medknow Publications | India

See All

Top Journals/Conferences in Pharmacology (medical)

Frontiers in Clinical Drug Research - Alzheimer Disorders
Bentham Science Publishers B.V. | Netherlands

P and T
MediMedia USA Inc. | United States

Journal of Population Therapeutics and Clinical Pharmacology
Dougmar Publishing Group Inc. | Canada

Pharmacien Hospitalier et Clinicien
Elsevier Masson s.r.l. | France

Clinical Pharmacist
Pharmaceutical Press | United Kingdom

Australian Journal of Pharmacy
Australian Pharmaceutical Publishing Company Ltd | Australia

Archivos Venezolanos de Farmacologia y Terapeutica
Sociedad Latinoamericana de Hipertension | Venezuela

See All

Top Journals/Conferences in Cancer Research

Cancer Microenvironment
Springer Netherlands | Netherlands

See All